Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.

Cancer - 1 Mar 2015

Bhatia Smita

Abstract excerpt

Subsequent malignant neoplasms (SMNs) are associated with significant morbidity and are a major cause of premature mortality among cancer survivors. Several large studies have demonstrated a strong association between the radiation and/or chemotherapy used to treat primary cancer and the risk of developing SMNs. However, for any given therapeutic exposure, the risk of developing an SMN varies between individuals....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to DNA Damage
Share to DNA Repair

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Neoplasms

Share to Neoplasms, Radiation-Induced

Share to Neoplasms, Second Primary

Share to Radiotherapy

Source

Open in PubMed Open full text

Identifiers

PMID: 25355167
DOI: 10.1002/cncr.29096
PMCID: PMC4339370

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.PMID 25355167Read ↗

Radiotherapy-Induced Malignancies: Review of Clinical Features, Pathobiology, and Evolving Approaches for Mitigating RiskSemantic proximity Read ↗

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.Semantic proximity Read ↗

Radiogenomics: the search for genetic predictors of radiotherapy response.Semantic proximity Read ↗

Genetic Risk of Second Malignant Neoplasm after Childhood Cancer Treatment: A Systematic Review.Semantic proximity Read ↗

Radiogenomics - current status, challenges and future directions.Semantic proximity Read ↗

Genetics and genomics of radiotherapy toxicity: towards predictionSemantic proximity Read ↗

Radiation biology and oncology in the genomic eraSemantic proximity Read ↗

Genetic susceptibility to radiogenic cancer in humans.Semantic proximity Read ↗

Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.Semantic proximity Read ↗

Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Semantic proximity Read ↗

Second malignant neoplasms and cardiovascular disease following radiotherapy.Semantic proximity Read ↗

Genetic variation in radiation-induced cell death.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.